Anti-inflammatory action of human cholochrome cholelith (HCC) were investigated.
对人胆色素结石的抗炎作用进行了研究。
HCC is a primary cancer of the liver.
肝细胞癌是肝脏的原发性癌症。
Objective:To study the features of HCC on low-field MR.
目的：分析肝细胞癌在低场MR的征象。
These results open a new avenue in clinical trial research in HCC.
这些结果为HCC的临床试验研究开辟了一条新的途径。
"Whether and why hypothyroidism causes HCC is not clear," the authors write.
“甲状腺功能低下是否以及为什么能引起HCC仍然不清楚，”作者们写到。
International Digest: Finally, how can we predict the prognosis of patients with HCC?
国际肝病：最后，我们如何来预测肝癌患者预后？
But around 70% of early HCC shows decreased portal supply on CT arterial portography.
但是，大约70%早期HCC中，其CT经动脉门脉造影显示门脉供血减少。
What is the current study status about insulin resistance as the risk factors for HCC?
请您谈一下目前对HCC的危险因素胰岛素抵抗的研究进展？
Hepatology Digest: As we know early detection of HCC is critical in improving prognosis.
《国际肝病》：正如我们所知道的那样，早期诊断hcc是改善预后的关键。
Could you give us a brief introduction to some of the novel therapeutic targets for HCC?
您能给我们简要介绍一些新的HCC靶向治疗策略吗？
Analysis of LSF level in biopsy material may one day be used as a prognostic marker for HCC.
对活检标本lsf水平的分析，有朝一日可以被用来作为肝癌的预后指标。
Treatment options for HCC include chemotherapy, chemoembolization, ablation and proton-beam therapy.
肝癌的治疗选择包括化疗、栓塞、消融和质子束疗法。
Further clinical trials using biologic agents are warranted to prolong the survival in HCC patients.
更进一步，使用生物因子的临床实验证实能延长肝癌患者的生存时间。
Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.
联合这些分子标志物能帮助提高器官在HCV -肝细胞癌患者中的分配。
Heptology Digest: What is your opinion about the possible mechanism for insulin-resistance causing HCC?
国际肝病：您怎么看胰岛素抵抗导致HCC可能的机制？
International Digest: Currently most of the therapeutic strategies for HCC are not totally satisfactory.
国际肝病：目前大多数的HCC治疗策略不能令人完全满意。
Summary Ongoing trials are evaluating the role of other targeted therapies in patients with advanced HCC.
正在进行的一些试验是评估其它靶向治疗对于进展期肝癌的病人的作用。
Would you please give us a brief introduction about the latest progress in interventional therapy for HCC?
您能给我们简要介绍一下肝癌介入治疗的最新进展吗？
Hepatology Digest: Early detection of HCC is obviously very important for the treatment and prognosis of HCC.
国际肝病：显然早期发现肝癌对于治疗和预后十分重要。
The team is currently testing small molecule inhibitors of LSF as a possible therapy for HCC in animal models.
该小组目前正在肝癌动物模型中验证LSF的小分子抑制剂，作为可能的治疗方法。
At present, interventional therapy is still the more effective treatment strategy for unresectable HCC patients.
目前，介入治疗仍然是不能切除肝癌患者更有效的治疗策略。
Hepatology Digest: When we compare to other types of tumors, what are the prospects for HCC in targeted therapy?
国际肝病：当我们比较其他类型的肿瘤时，肝癌靶向治疗的前景如何？
HCC shares fell as much as 6.3 percent in early trade but later recovered in the afternoon and were flat at 1330 GMT.
HCC的股票在早盘交易中降低了6.3%然后恢复，在下午格林尼治标准时间1：30持平。
HCV infection can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) or primary liver cancer.
丙肝病毒可以导致慢性肝炎，肝硬化，肝细胞肝癌或原发性肝癌。
Objective to analyze the pathologic basis and ct features of spontaneous rupture in hepatocellular carcinoma (HCC).
目的分析原发性肝细胞癌(HCC)自发性破裂出血的病理基础及CT特点。
Hepatology Digest: What imaging markers must clinician pay attention to when they are trying to diagnose HCC early?
《国际肝病》：当临床医生尝试早期诊断hcc时，他们应该注意哪些影像学指标？
An older age at time of cirrhosis diagnosis and a higher BMI were negatively associated with the development of HCC.
诊断肝硬化时较大的年龄和较高的体重指数，与HCC的发生存在阴性相关。
Results indicate three factors that are statistically significant in the development of HCC within the NASH-cirrhosis group.
研究结果显示：有三个因素与NASH相关性肝硬化组肝细胞癌的发生存在统计学意义。
Although these patients receive systemic treatment including chemotherapy, HCC is generally recognized as a chemo-resistant tumor.
虽然这些病人得到了包括化疗在内的系统化治疗，肝癌通常被认为是化疗抵抗性肿瘤。
It has been showed that both short and long term survival after LT was not compromised by previous partial liver resection of HCC.
一些研究也证实了进行肝癌部分肝切除不能改善肝癌患者短期和长期的存活率。
应用推荐